Goa Medical College starts using pertuzumab for HER2-positive breast cancer patients
Panaji: The Goa Medical College (GMC) on Sunday started using pertuzumab, a modern drug, expanding its treatment protocol for a subset of breast cancer patients, state health minister Vishwajit Rane said.
The initiative was launched on World Cancer Day, which is observed on February 4 every year to raise awareness of the disease and encourage its prevention, detection and treatment.
He said the medicine will be used to treat HER2-positive breast cancer patients, who test positive for a protein called human epidermal growth factor receptor 2, and they will get it for free.
Also Read: GMC Goa to provide free IVF treatment from September 1
This protein promotes the growth of cancer cells. In about one of every five breast cancer cases, the cancer cells have extra copies of the gene that makes the HER2 protein, he said.
“Recognizing the evolving landscape of cancer therapeutics, the medical community at GMC has now incorporated pertuzumab, a second antibody, into the treatment regimen,” Rane told reporters.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.